Your browser doesn't support javascript.
IMMUNOTHERAPY WITH B CELL ACTIVATING ANTIBODY CPI-006 IN PATIENTS (PTS) WITH MILD TO MODERATE COVID-19 STIMULATES ANTI-SARS-COV-2 ANTIBODY RESPONSE, MEMORY B CELLS AND MEMORY T EFFECTOR CELLS
Journal for Immunotherapy of Cancer ; 8:A199-A200, 2020.
Article in English | Web of Science | ID: covidwho-1105513

Full text: Available Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies Language: English Journal: Journal for Immunotherapy of Cancer Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies Language: English Journal: Journal for Immunotherapy of Cancer Year: 2020 Document Type: Article